title: [Modern medical support for smoking cessation].
abstract: In view of the high morbidity and mortality associated with tobacco, smoking cessation is one of the most urgent medical challenges. It is effective when psychosocial support is combined with accompanying medication. In view of the associated rate of occurrence of cardiovascular diseases, COPD/emphysema as well as lung cancer, it is highly cost-effective. The nicotine replacement substances Bupropion and Varenicline used in smoking cessation therapies demonstrate a well-documented increase in effectiveness. Their use is not complicated. An increase in the overall cessation success rate by a factor of 2-3 is obtained when using an accompanying course of medication.
authors.affiliation: hering@t-online.de
authors.forename: T
authors.initials: T
authors.lastname: Hering
mesh_terms: D001552:Benzazepines / Q000008:administration & dosage*; D016642:Bupropion / Q000008:administration & dosage*; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage*; D010818:Practice Patterns, Physicians' / Q000639:trends*; D011810:Quinoxalines / Q000008:administration & dosage*; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D011810:Quinoxalines; D016642:Bupropion; D009538:Nicotine; D000068580:Varenicline